alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT 13.2

CERTIFICATION OF CHIEF FINANCIAL
		OFFICER

PURSUANT TO SECTION 906 OF THE
		SARBANES-OXLEY ACT OF 2002

Pursuant to 18 U.S.C. 1350, as created by
		Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of
		Olympus Pacific Minerals Inc. (the Company) hereby certifies, to
		such officers knowledge, that:

(i) the accompanying Annual Report on Form
		20-F of the Company for the fiscal year ended December 31, 2006 (the
		Report) fully complies with the requirements of Section 13(a) or
		Section 15(d), as applicable, of the Securities Exchange Act of 1934, as
		amended; and

(ii) the information contained in the Report
		fairly presents, in all material respects, the financial condition and results
		of operations of the Company.



|Date: July 13, 2007 |  |  |                        
|------------------- |  |  | -----------------------
|                    |  |  | /s/ Peter Tiedemann    
|                    |  |  | Peter Tiedemann        
|                    |  |  | Chief Financial Officer

The foregoing certifications are being
		furnished solely to accompany the Report pursuant to 18 U.S.C. 1350, and are
		not being filed for purposes of Section 18 of the Securities Exchange Act of
		1934, as amended, and are not to be incorporated by reference into any filing
		of the Company, whether made before or after the date hereof, regardless of any
		general incorporation language in such filing.





---
(38 App. Div. 139.)

#### PALMER v. SALISBURY et al.

(Supreme Court, Appellate Division, First Department.

March 10, 1899.)

Amendment of Complaint—Service of Copt.

Where a complaint is amended, a copy should be served on defends»;', and the latter given an opportunity to answer, though he has not answered the original complaint.

Appeal from special term, New York county.

Action by Miln P. Palmer, trustee, against Pasquale Altieri anS others, impleaded with Nelson H. Salisbury. From an order allowing an amendment to the complaint, Nelson H. Salisbury appeals.

Reversed.

Argued- before VAN BRUNT, P. J., and BARRETT, RUMSEY,. McLaughlin, and ingraham, jj.

Henry G. Atwater, for appellant.

Howard McWilliams, for respondent.

RUMSEY, J.

There can be no doubt that the court had power in the proper case to allow the amendment to the complaint; but ike rule is almost without exception that, whenever a complaint has beeu amended, it is necessary that a copy of it should be served upon the defendant, and that he should have an opportunity to answer it, ft; he desires. The fact that he has defaulted in answering the original complaint is of no importance. It may well be that he did Krai choose to answer the original complaint, but that he might desire to put in issue the facts which the plaintiff-finds it necessary t© allege by the amendment. The order therefore was erroneous in permitting the amendment of this complaint without giving the defendant an opportunity to answer.

For this reason, the order should be reversed, with $10 costs and disbursements, and the motion denied, with $10 costs, without prejudice to a motion on the part of the plaintiff, upon payment of above costs, to set aside the judgment, and serve an amended complaint, if he shall be so advised. All concur.
U.S. flagAn official website of the United States government
                    Here's how you know **Official websites use .gov**
                            
                            A **.gov** website belongs to an official government organization in the United States.
 **Secure .gov websites use HTTPS**
                            
                            A **lock** (                            
                              A locked padlock                                                      
                            
                            ) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.


Menu Agricultural Research Service
						
                    U.S. DEPARTMENT OF AGRICULTURE
 Forage and Range Research: Logan, UT
 close



    Research

                    Research Projects
                                    Publications
                                    Collaborations
                                    News
                People

                    Staff Listing
                                    CareersSearch small
                    Search
            
            ARS Home
                                About ARS
                                Contact Us




The FRRL is composed of a multidisciplinary team that has developed critically important plant materials presently used on the western U.S. rangelands and pastures. We invite you to learn more about us, how we operate, and our products.
 The FRRL mission is to provide improved plant materials and management alternatives for sustainable stewardship of rangelands, pastures, and turf in the western U.S.
 Research at the FRRL is accomplished through associations among laboratory scientists and their cooperators, under the broad umbrella of pasture, rangeland, turf, and biomass production. Click the image to the left to visit the Working Groups page and download their respective trifolds.
 The primary products of the FRRL are improved plant materials that include grasses, legumes, and forbs. Please click the image to visit the Germplasm Releases page and view the interactive catalog.


Mission


People Buffham, James
                                            *- Ramsey* Bushman, Shaun Forsyth, Kyle Hafele, Anna Hernandez, Alexander Israelsen, Benson Johnson, Brittany Jones, Thomas Klein, Angelia Larson, Steven Mills, Dylan Monaco, Thomas Peel, Michael Rigby, Craig Robbins, Matthew Robins, Joseph Shafer, Carol Thorsted, Kimberly Waldron, Blair Wang, Richard


Pacific West Area   blair.waldron@ars.usda.gov


Connect with ARS Sign up


ARS Home
                            USDA.gov
                            Plain Writing
                            Policies & Links
                            Civil Rights Statements
                            FOIA
                            Accessibility Statement
                            Privacy Policy
                            Non-Discrimination Statement
                            Quality of Information
                            USA.gov
                            WhiteHouse.gov
EXHIBIT
      23.2




**CONSENT
      OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**




We
      consent to the incorporation by reference in Registration Statements of
      InfoSearch Media, Inc. on Forms S-8 (No. 333-139277, 333-134726 and
      333-125210) of our report, dated April 17, 2007, relating to our audit of the
      consolidated financial statements, which appears in this Annual Report on Form
      10-KSB of InfoSearch Media, Inc. for the year ended December 31,
      2007.




/s/ SINGER
      LEWAK GREENBAUM & GOLDSTEIN LLP




Los
      Angeles, CA


April
      11,
      2008
# In the United States Court of Federal Claims

OFFICE OF SPECIAL MASTERS

No. 16-0639V Filed: September 7, 2016

UNPUBLISHED

* * * * * * * * * * * * * * * * * * * * * * * * * * * * SHARON G. ORTAGUS, *

* Petitioner, * Ruling on Entitlement; Concession; v. * Influenza (“Flu”) Vaccine; Shoulder * Injury Related to Vaccine Administration SECRETARY OF HEALTH * (“SIRVA ”); Special Processing Unit AND HUMAN SERVICES, * (“SPU”)

* Respondent. *

*

* * * * * * * * * * * * * * * * * * * * * * * * * * * * Leah VaSahnja Durant, Law Offices, Wa shington, D.C.,, for petitioner. Douglas Ross, U.S. Department of Just ice, Washington, DC, for respondent.

RULING ON ENTITLEMENT 1

Dorsey , Chief Special Master:

On May 27, 2016, Sharon G. Ortagus (“petitioner”) filed a petition for compensation under the National Vaccine Inju ry Compensation Program, 42 U.S.C. §300aa-10, et seq.

, 2 (the “Vaccine Act”). Petitioner alleges that she suffered a shoulder injury related to vaccine administration (“SIR VA”) as a result of receiving an influenza (“flu”) vaccine on October 13, 2015. Petiti on at 1. The case was assigned to the Special Processing Unit of the Office of Special Masters.

On September 7, 2016, respondent filed her Rule 4(c) report in which she concedes that petitioner is entitled to compen sation in this case. Respondent’s Rule

1 Because this unpublished ruling contains a reaso ned explanation for the action in this case, the undersigned intends to post it on the United States Cour t of Federal Claims' website, in accordance with

the E-Government Act of 2002. 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic Government Services). In accordance with Vaccine Rule 18(b), petitioner has 14 days to identify and move to redact medical or other inform ation, the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, t he undersigned agrees that the identified material fits within this definition, the undersigned will redact such material from public access.

2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease of citation, all “§” references to the Vaccine Ac t will be to the pertinent subparagraph of 42 U.S.C. § 300aa (2012).2 4(c) Report at 1. 3 Specifically, respondent conclude d that petitioner suffered SIRVA and that a preponderance of the evidence indicates that t he injury was causally related
to the flu vaccine Id. at 5. Respondent further agrees that petitioner me t the statutory requirements by suffering her condition for more than six months. Id.

In view of respondent’s concession and the evidence before me, the undersigned finds that petitioner is entitled to compensation.

IT IS SO ORDERED.

s/Nora Beth Dorsey Nora Beth Dorsey Chief Special Master

3 The Rule 4(c) report, on page 1 and page 5, incorrectly references the date of vaccination as November 10, 2014. The flu vaccine was administered to petitioner on October 13, 2015. See Petition at 1; Pet. Ex.

1 at 1.
#### D’AMATO et al., Appellants, v. SILVER-MAN, Respondent.

(Supreme Court, Appellate Division, First Department.

March 29, 1912.)

Action by Giovanni D’Amato and others against Morris R. Silverman. S. A. Berger, for appellants. A. Rosenstein, for respondent. No opinion. Order affirmed, with $10 costs and disbursements. Order filed.
EXHIBIT 31.2 CERTIFICATE OF CHIEF FINANCIAL OFFICER I, S. Colin
Neill, certify that: 1. I have
reviewed this quarterly report on Form 10-Q of Pharmos Corporation; 2. Based on my
knowledge, this report does not contain any untrue statement of a material fact
or omit to state a material fact necessary to make the statements made, in
light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report; 3. Based on my
knowledge, the financial statements, and other financial information included
in this report, fairly present in all material respects the financial
condition, results of operations and cash flows of the registrant as of, and
for, the periods presented in this report; 4. The
registrants other certifying officer and I are responsible for establishing
and maintaining disclosure controls and procedures (as defined in Exchange Act
Rules 13a-15(e) and 15d-15(e)) for the registrant and have: (a)
designed such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that
material information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly
during the period in which this report is being prepared; (b)
evaluated the effectiveness of the registrants disclosure controls and
procedures and presented in this report our conclusions about the effectiveness
of the disclosure controls and procedures, as of the end of the period covered
by this report based on such evaluation; and (c)
disclosed in this report any change in the registrants internal control over
financial reporting that occurred during the registrants most recent fiscal
quarter (the registrants fourth fiscal quarter in the case of an annual
report) that has materially affected, or is reasonably likely to materially
affect, the registrants internal control over financial reporting; and 5. The
registrants other certifying officer and I have disclosed, based on our most
recent evaluation of internal control over financial reporting, to the
registrants auditors and the audit committee of the registrants board of
directors (or persons performing the equivalent functions): (a)
all significant deficiencies and material weaknesses in the design or operation
of internal control over financial reporting which are reasonably likely to
adversely affect the registrants ability to record, process, summarize and
report financial information; and (b)
any fraud, whether or not material, that involves management or other employees
who have a significant role in the registrants internal control over financial
reporting. /s/ S. COLIN
  NEILLS. Colin
  NeillChief
  Financial OfficerDate: August
  8, 2007
I 

109TH CONGRESS 

1ST SESSION H. R. 1997

To amend the Harmonized Tariff Schedule of the United States to clarify 

the article description relating to certain monochrome glass envelopes, 

and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

APRIL 28, 2005

Mr. MANZULLO introduced the following bill; which was referred to the 

Committee on Ways and Means 

A BILL

To amend the Harmonized Tariff Schedule of the United 

States to clarify the article description relating to certain 

monochrome glass envelopes, and for other purposes.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. CERTAIN MONOCHROME GLASS ENVELOPES. 

4 (a) AMENDMENT TO SUBHEADING 7011.20.40 OF

5 HTSUS.—The article description of subheading 

6 7011.20.40 of the Harmonized Tariff Schedule of the 

7 United States is amended to read as follows: ‘‘Mono8 chrome glass envelopes, the foregoing certified by the im-
2

•HR 1997 IH 

1 porter as being for actual use in automatic data processing 

2 machine data or graphic display cathode ray tubes’’. 

3 (b) CONFORMING AMENDMENTS.—(1) Subheading 

4 7011.20.40 of the Harmonized Tariff Schedule of the 

5 United States, as amended by subsection (a), is redesig6 nated as subheading 7011.20.45. 

7 (2) Subheading 7011.20.80 of such Schedule is redes8 ignated as subheading 7011.20.85. 

9 (3) Subchapter II of chapter 99 of such Schedule is 

10 amended by striking heading 9902.70.01. 

11 (c) STAGED RATE REDUCTIONS.—Any staged rate 

12 reduction of a rate of duty proclaimed by the President 

13 before the date of the enactment of this Act, that—

14 (1) would take effect on or after such date of 

15 enactment; and 

16 (2) would, but for the amendment made by sub17 section (b)(2), apply to subheading 7011.20.80 of 

18 the Harmonized Tariff Schedule of the United 

19 States, 

20 applies to the corresponding rate of duty set forth in sub21 heading 7011.20.85 of such Schedule (as added by sub22 section (b)(2)).

Æ
UNITED STATES DISTRICT COURT 

NORTHERN DISTRICT OF INDIANA 

HAMMOND DIVISION 

UNITED STATES OF AMERICA, 

 Plaintiff, 

v. Case No. 2:14-CR-4 JVB 

Rita Law, et al., 

 Defendants. 

ORDER 

 Without an objection from Defendant Rita Law, the Government agreed to provide 

additional information after Ms. Law’s sentencing hearing regarding the restitution amount owed 

to her victims. 

 The government’s supplemental filing sets out in detail the past and reasonable future 

losses the two victims have suffered and will suffer as a result of Ms. Law’s crimes against them. 

XC’s loss is $234,800 and HV’s loss is $79,351. 

 In response, Ms. Law does not dispute the losses; she merely maintains her innocence 

and hopes to be vindicated on appeal. 

 Having considered the government’s submissions, the Court finds that it has adequately 

proved the victims’ losses. Accordingly, the Court orders--- 

Defendant Law to pay $234,800 in restitution to victim XC, and $79,351 in 

restitution to victim HV. The restitution payme must be made to the Clerk of the 

Court in this judicial district. 

The Clerk of the Court is ordered, in turn, to divide all funds received from Defendant 

Law at the ratio of 3⁄4 for XC and 1⁄4 for HV, and disburse the funds to them until each is paid in 

full: 

USDC IN/ND case 2:14-cr-00004-JVB-JEM document 497 filed 09/09/19 page 1 of 2
2 

 Victim XC, c/o Roxanne Mendez Johnson, at 2929 Carlson Drive, Suite 

101, Hammond, IN 46323 (Telephone: 219-937-8020); 

 Victim HV, c/o Heather Benno, 1629 K. Street NW, #300, Washington, 

DC, 20006 (Telephone: 240-435-7191). 

SO ORDERED on September 9, 2019. 

 

s/ Joseph S. Van Bokkelen 

JOSEPH S. VAN BOKKELEN 

UNITED STATES DISTRICT JUDGE 

USDC IN/ND case 2:14-cr-00004-JVB-JEM document 497 filed 09/09/19 page 2 of 2
USDC IN/ND case 2:13-cr-00084-PPS-PRC document 1 filed 05/24/13 page 1 of 12
USDC IN/ND case 2:13-cr-00084-PPS-PRC document 1 filed 05/24/13 page 2 of 12
USDC IN/ND case 2:13-cr-00084-PPS-PRC document 1 filed 05/24/13 page 3 of 12
USDC IN/ND case 2:13-cr-00084-PPS-PRC document 1 filed 05/24/13 page 4 of 12
USDC IN/ND case 2:13-cr-00084-PPS-PRC document 1 filed 05/24/13 page 5 of 12
USDC IN/ND case 2:13-cr-00084-PPS-PRC document 1 filed 05/24/13 page 6 of 12
USDC IN/ND case 2:13-cr-00084-PPS-PRC document 1 filed 05/24/13 page 7 of 12
USDC IN/ND case 2:13-cr-00084-PPS-PRC document 1 filed 05/24/13 page 8 of 12
USDC IN/ND case 2:13-cr-00084-PPS-PRC document 1 filed 05/24/13 page 9 of 12
USDC IN/ND case 2:13-cr-00084-PPS-PRC document 1 filed 05/24/13 page 10 of 12
USDC IN/ND case 2:13-cr-00084-PPS-PRC document 1 filed 05/24/13 page 11 of 12
USDC IN/ND case 2:13-cr-00084-PPS-PRC document 1 filed 05/24/13 page 12 of 12
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          SEP-30-1996
<PERIOD-START>                             OCT-01-1996
<PERIOD-END>                               DEC-31-1996
<CASH>                                             610
<SECURITIES>                                         0
<RECEIVABLES>                                    5,113
<ALLOWANCES>                                         0
<INVENTORY>                                        559
<CURRENT-ASSETS>                                 6,425
<PP&E>                                           8,449
<DEPRECIATION>                                   7,206
<TOTAL-ASSETS>                                  10,511
<CURRENT-LIABILITIES>                            4,719
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           140
<OTHER-SE>                                       4,318
<TOTAL-LIABILITY-AND-EQUITY>                    10,511
<SALES>                                          5,356
<TOTAL-REVENUES>                                 5,356
<CGS>                                            2,113
<TOTAL-COSTS>                                    4,905
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                  10
<INCOME-PRETAX>                                    544
<INCOME-TAX>                                       106
<INCOME-CONTINUING>                                438
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       438
<EPS-PRIMARY>                                      .16
<EPS-DILUTED>                                      .16
        

</TABLE>
USDC IN/ND case 3:15-cv-00463-JD document 10 filed 10/13/15 page 1 of 3
USDC IN/ND case 3:15-cv-00463-JD document 10 filed 10/13/15 page 2 of 3
10/13/2015 s/Christopher A Nuechterlein

USDC IN/ND case 3:15-cv-00463-JD document 10 filed 10/13/15 page 3 of 3
EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Golden Pond Healthcare, Inc. (the Company) on
Form 10-K for the period ending December 31, 2008, as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Michael C. Litt, as Chief Financial Officer and Secretary of the Company, certify, pursuant
to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the
requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report
fairly presents, in all material respects, the financial condition and results of operations of the Company.



|                                     
|-------------------------------------
|/s/ Michael C. Litt                  
|Michael C. Litt                      
|Chief Financial Officer and Secretary

Date: March 16, 2009
<TABLE> <S> <C>

<ARTICLE>          5


<LEGEND>          THIS SCHEDULE CONTAINS SUMMARY FINANCIAL
STATEMENTS INCLUDED
                  IN THE REGISTRANT'S QUARTERLY REPORT ON FORM 10Q
FOR THE
                  QUARTER ENDED SEPTEMBER 30, 1998 AND IS
QUALIFIED IN ITS
                  ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>
<MULTIPLIER>         1,000

       
<S>                                           <C>

<PERIOD-TYPE>                                       9-MOS
<FISCAL-YEAR-END>                             DEC-31-1998
<PERIOD-START>                                JAN-01-1998
<PERIOD-END>                                  SEP-30-1998
<CASH>                                            198,823
<SECURITIES>                                            0
<RECEIVABLES>                                     515,653
<ALLOWANCES>                                            0
<INVENTORY>                                             0
<CURRENT-ASSETS>                                        0
<PP&E>                                         16,477,552
<DEPRECIATION>                                  1,910,592
<TOTAL-ASSETS>                                 14,566,960
<CURRENT-LIABILITIES>                                   0
<BONDS>                                        10,518,966
<COMMON>                                            3,582
<PREFERRED-MANDATORY>                                   0
<PREFERRED>                                       400,000
<OTHER-SE>                                              0
<TOTAL-LIABILITY-AND-EQUITY>                   16,412,783
<SALES>                                         1,362,800
<TOTAL-REVENUES>                                1,508,492
<CGS>                                                   0
<TOTAL-COSTS>                                     625,621
<OTHER-EXPENSES>                                        0
<LOSS-PROVISION>                                        0
<INTEREST-EXPENSE>                                477,318
<INCOME-PRETAX>                                   405,553
<INCOME-TAX>                                      142,750
<INCOME-CONTINUING>                               262,803
<DISCONTINUED>                                          0
<EXTRAORDINARY>                                         0
<CHANGES>                                               0
<NET-INCOME>                                      262,803
<EPS-PRIMARY>                                           0
<EPS-DILUTED>                                           0
        

</TABLE>